Assessment of patellar cartilage cross-sectional area in patients with lower grade chondromalacia patella
- PMID: 37603532
- PMCID: PMC10443766
- DOI: 10.1097/MD.0000000000034307
Assessment of patellar cartilage cross-sectional area in patients with lower grade chondromalacia patella
Abstract
Chondromalacia patella (CMP) is abnormal softening of the cartilage of the underside the patella. It is a cause of anterior knee pain. Previous study has demonstrated that the patellar cartilage hypertrophy is correlated with early signs of CMP (Grade 1 or 2). However, no studies have investigated the clinical cutoff value of patella cartilage hypertrophy. Thus, we devised the patellar cartilage cross-sectional area (PCCSA) as a new predictive parameter for diagnosing the CMP. The purpose of this research was to compare MR measured PCCSA between CMP patients and gender matched healthy controls. The PCCSA samples were collected from 50 patients with CMP, and from 50 healthy controls who underwent knee MRI with no evidence of CMP. The T2-weighted turbo spin echo transverse MRI images were acquired. We measured the PCCSA on MRI using a PACS system. The PCCSA was measured on the axial angled sections through the whole images by drawing outlines. The average PCCSA was 104.28 ± 23.28 mm2 in the healthy controls and 134.09 ± 26.55 mm2 in the CMP group. CMP patients had significantly higher PCCSA (P < .001). Regarding the validity of PCCSA as predictors of CMP, Receiver Operating Characteristic curve analysis showed that the best cutoff point for the PCCSA was 116.24 mm2, with 72.0% sensitivity, 72.0% specificity, and the area under curve (AUC) of 0.79 (0.71-0.88). The PCCSA is a sensitive measurement parameter to predict low grade CMP. Thus, to evaluate CMP patients, the treating physician carefully inspect the PCCSA.
Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures


Similar articles
-
Patella-patellar tendon angle in relation to the medial patellar plica syndrome, chondromalacia patella, and infrapatellar fat pad syndrome.PLoS One. 2022 Mar 17;17(3):e0265331. doi: 10.1371/journal.pone.0265331. eCollection 2022. PLoS One. 2022. PMID: 35298516 Free PMC article.
-
A comparison of isokinetic muscle strength in patients with chondromalacia patella: a cross-sectional study.Eur Rev Med Pharmacol Sci. 2022 Nov;26(21):7771-7778. doi: 10.26355/eurrev_202211_30126. Eur Rev Med Pharmacol Sci. 2022. PMID: 36394724
-
Usefulness of patellar cartilage cross-sectional area for knee tibiofemoral osteoarthritis in elderly.Clin Interv Aging. 2019 Jun 5;14:1021-1026. doi: 10.2147/CIA.S205027. eCollection 2019. Clin Interv Aging. 2019. PMID: 31239652 Free PMC article.
-
Chondromalacia patellae: current options and emerging cell therapies.Stem Cell Res Ther. 2021 Jul 18;12(1):412. doi: 10.1186/s13287-021-02478-4. Stem Cell Res Ther. 2021. PMID: 34275494 Free PMC article. Review.
-
Current concepts of etiology and treatment of chondromalacia patellae.Clin Orthop Relat Res. 1984 Oct;(189):209-28. Clin Orthop Relat Res. 1984. PMID: 6383677 Review.
References
-
- Duran S, Cavusoglu M, Kocadal O, et al. . Association between trochlear morphology and chondromalacia patella: an MRI study. Clin Imaging. 2017;41:7–10. - PubMed
-
- Tuna BK, Semiz-Oysu A, Pekar B, et al. . The association of patellofemoral joint morphology with chondromalacia patella: a quantitative MRI analysis. Clin Imaging. 2014;38:495–8. - PubMed
-
- Zha GC, Feng S, Chen XY, et al. . Does the grading of chondromalacia patellae influence anterior knee pain following total knee arthroplasty without patellar resurfacing? Int Orthop. 2018;42:513–8. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical